Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ASCENDIS PHARMA A/S

(ASND)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ASCENDIS PHARMA A/S
01/13Wedbush Raises Price Target for Ascendis Pharma A/S to $189 From $186 on EU Approval fo..
MT
01/13Ascendis Pharma's Growth Hormone Drug TransCon hGH Gets EU Approval
MT
01/13Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Gr..
AQ
01/13Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Gro..
CI
01/13Wedbush Cuts Ascendis Pharma's PT to $186 From $191 on Skytrofa Contraindication for PW..
MT
01/10Ascendis Pharma A/S Provides Update on Vision 3x3 Strategic Roadmap at 40th Annual J.P...
AQ
01/06Cowen Starts Ascendis Pharma at Market Perform With $136 Price Target
MT
01/04Ascendis Pharma A/S to Participate in 40th Annual J.P. Morgan Healthcare Conference
GL
2021Ascendis Pharma A/S Virtual R&D Program Update Highlights Continued Development Across ..
AQ
2021Ascendis Pharma A/S to Provide an Update on Two of Its Investigational Endocrinology Ra..
CI
2021Wells Fargo Starts Ascendis Pharma at Overweight With $176 Price Target
MT
2021Ascendis Pharma A/S to Host Virtual R&D Program Update on December 14
GL
2021Ascendis Pharma A/S Announces Top-Line Results from Week 84 of Its Phase 2 PaTH Forwar..
GL
2021Ascendis Pharma A/S Announces Top-Line Results from Week 84 of Its Phase 2 PaTH Forward..
CI
2021Ascendis Pharma A/S Elects Rafa?le Tordjman as A Class II Director
CI
More most relevant news
All news about ASCENDIS PHARMA A/S
01/13Wedbush Raises Price Target for Ascendis Pharma A/S to $189 From $186 on EU Approval fo..
MT
01/13Ascendis Pharma's Growth Hormone Drug TransCon hGH Gets EU Approval
MT
01/13Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Gr..
AQ
01/13Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Gro..
CI
01/13Wedbush Cuts Ascendis Pharma's PT to $186 From $191 on Skytrofa Contraindication for PW..
MT
01/11European ADRs Nudge Lower in Tuesday Trading
MT
01/10Ascendis Pharma A/S Provides Update on Vision 3x3 Strategic Roadmap at 40th Annual J.P...
AQ
01/06European ADRs Move Higher in Thursday Trading
MT
01/06Cowen Starts Ascendis Pharma at Market Perform With $136 Price Target
MT
01/05European ADRs Move Higher in Wednesday Trading
MT
More news
News in other languages on ASCENDIS PHARMA A/S
01/13Ascendis Pharma A/S reçoit l'approbation européenne de TransCon hGH pour le déficit en ..
01/11Les ADR européens en baisse dans les échanges de mardi
01/06Les ADR européens sont en hausse jeudi
01/05Les ADR européens sont en hausse mercredi
2021Les ADR européens en forte baisse dans la négociation de vendredi
2021Panorama des ADR européens dans les échanges de mardi matin
2021Ascendis Pharma déclare que le panel de l'EMA émet un avis favorable à l'approbation du..
2021La perte d'Ascendis Pharma au troisième trimestre se réduit malgré la baisse des revenu..
2021Les ADR européens en baisse mercredi
2021Ascendis Pharma rachètera jusqu'à 25 millions de dollars d'American Depositary Shares d..
More news
Analyst Recommendations on ASCENDIS PHARMA A/S
01/13Wedbush Raises Price Target for Ascendis Pharma A/S to $189 From $186 on EU Approval fo..
MT
01/13Wedbush Cuts Ascendis Pharma's PT to $186 From $191 on Skytrofa Contraindication for PW..
MT
01/06Cowen Starts Ascendis Pharma at Market Perform With $136 Price Target
MT
2021Wells Fargo Starts Ascendis Pharma at Overweight With $176 Price Target
MT
2021SVB Leerink Adjusts Ascendis Pharma's Price Target to $190 from $182, Keeps Outperform ..
MT
More recommendations
Press releases
01/13Ascendis Pharma A/S Receives European Approval for TransCon™ hGH for Pediatric Gr..
AQ
01/10Ascendis Pharma A/S Provides Update on Vision 3x3 Strategic Roadmap at 40th Annual J.P...
AQ
01/04Ascendis Pharma A/S to Participate in 40th Annual J.P. Morgan Healthcare Conference
GL
2021Ascendis Pharma A/S Virtual R&D Program Update Highlights Continued Development Across ..
AQ
2021Ascendis Pharma A/S to Host Virtual R&D Program Update on December 14
GL
More press releases
Upcoming event on ASCENDIS PHARMA A/S
04/06/22